Previous 10 | Next 10 |
Jazz Pharmaceuticals (NASDAQ: JAZZ) is a cross between a pharmaceutical stock and a cannabis stock. In its earlier life, it was a pharmaceutical company that was chugging along and posting some good numbers. But after it acquired GW Pharmaceuticals earlier this year, that changed. N...
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults Xywav is the first and only FDA-approved treatment for idiopathic hypersomnia Individualized Xywav dosing r...
Campbell CA - ( NewMediaWire ) - August 11, 2021 - Friendable Inc. (OTC: FDBL), a mobile technology and marketing company, is pleased to announce its two new video trailers, designed to showcase the Fan Pass Livestream platform and entice both artists and music fans around the world to sign ...
Stand Up To Cancer And Jazz Pharmaceuticals Collaborate To Fund Catalyst Research On Hard-To-Treat Cancers $4 Million Research Collaboration to Explore New Treatment Options for Pediatric Solid Tumors or RAF, RAS Mutated Tumors PR Newswire LOS ANGELES , Aug. 10...
NetworkNewsWire Editorial Coverage New York, NY – August 5, 2021 – A leading cause of death in the United States for men and women of most racial and ethnic groups, heart disease is a pervasive health challenge that destroys lives. The Centers for Disea...
Avadel's once-nightly FT218 improves considerably over Xyrem's twice-nightly dosing. Jazz's recent lawsuit seems spurious, given how they lost to Amneal before. October PDUFA and current low prices make AVDL a compelling buy. For further details see: Avadel Pharmaceutica...
After the market closed on Tuesday, Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced financial results for the second quarter of 2021 and affirmed non-GAAP adjusted financial guidance for 2021. Jazz also said that it plans to expand the use of GW Pharmaceutical’s drug ...
The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2021 Q2 earnings call. For further details see: Jazz Pharmaceuticals plc 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 Earnings Call Aug 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript
Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Conference Call August 03, 2021 4:30 PM ET Company Participants Andrea Flynn – Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Renee Gala – Executive Vice President and Chief Financial Officer Dan Swi...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance PR Newswire – 15% year-over-year revenue increase from combined key growth drivers: Xywav ® , Epidiolex ® and Rylaze ® – – O...
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting PR Newswire Ms. Hamill brings extensive experience and proven leadership focused on commercial growth and shareholder value DUBLIN , July 25, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals In celebration of Pride Month , we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for unders...